Back
Spyre Therapeutics Vs. MarineMax Industry Stock Comparison
Sell
44
SYRE
Spyre Therapeutics
Last Price:
27.68
Seasonality Move:
3.13%
Buy
63
HZO
MarineMax
Last Price:
30.68
Seasonality Move:
17.71%
Sell
44
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $27.70. The Score for SYRE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
MarineMax (HZO)
is a Buy
Is MarineMax a Buy, Sell or Hold?
- The current MarineMax [HZO] share price is $30.56. The Score for HZO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- HZO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $27.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
HZO Stock Price Chart
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.19 | Sell |
| Relative Strength Index (14 RSI): | 36.88 | Sell |
| Chaikin Money Flow: | 402962 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.58 - 36.78) | Sell |
| Bollinger Bands (100): | (26.13 - 32.71) | Sell |
HZO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 50.05 | Buy |
| Chaikin Money Flow: | 42955 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.96 - 31.44) | Buy |
| Bollinger Bands (100): | (29.44 - 34.4) | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.9 | Sell |
| 20-day SMA: | 33.04 | Sell |
| 50-day SMA: | 31.15 | Sell |
| 200-day SMA: | 31.25 | Sell |
| 8-day EMA: | 29.24 | Sell |
| 20-day EMA: | 31.34 | Sell |
| 50-day EMA: | 31.19 | Sell |
| 200-day EMA: | 28.82 | Sell |
HZO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.83 | Buy |
| 20-day SMA: | 30.39 | Buy |
| 50-day SMA: | 31.8 | Sell |
| 200-day SMA: | 31.01 | Sell |
| 8-day EMA: | 30.02 | Buy |
| 20-day EMA: | 30.38 | Buy |
| 50-day EMA: | 31.01 | Sell |
| 200-day EMA: | 31.44 | Sell |
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.85 per share, and an increase next year of $0.14 per share.
MarineMax Earnings Growth & HZO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.10 per share, and an increase next year of $0.17 per share.
Spyre Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MarineMax Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||